The AOMA-funded virtual melanoma nurse is a new specialist telehealth service to support patients with ocular melanoma in remote and regional areas of Australia.

Professor H. Peter Soyer is focused on improving the early detection of skin cancer through a nationwide melanoma screening program.

MASC Trials is pleased to announce the appointment of Cheryl-Ann Hawkins as Chief Executive.

Building on the highly successful inaugural summit in 2019, The Australasian Ocular Melanoma Alliance (AOMA) Summit returns in 2021.

MASC Trials opens the Australian arm of the first global patient registry for uveal melanoma.

The board and staff of MASC Trials thank Libby Paton for her 12 years of service as Chief Executive Officer.

New data shows there has been a 73.6% reduction in referrals for melanoma between April and June 2020 when compared to the same period over the past three years, with COVID-19 restrictions suspected to be a major cause of people putting off appointments.

“It is a privilege to lead this important organisation,” says Aileen Boyd-Suires, Chief Executive of Melanoma and Skin Cancer Trials.

Join Dr Wen Xu, Prof. Gerald Fogarty and Jonathan Pincus for a discussion about the I-MAT clinical trial, which aims to improve the management of early stage Merkel Cell Carcinoma.